@inproceedings{inproceedings, title  = {{Prophylactic Ruxolitinib for Cytokine Release Syndrome (CRS) in Relapse/Refractory (R/R) AML Patients Treated with Flotetuzumab}},

 publisher = {{American Society of Hematology}},

 url = {{https://doi.org/10.1182/blood-2020-134612 }},

 year = {{2020}},

 month = {{11}},

 author = {{Uy GL and Rettig MP and Christ S and Aldoss I and Byrne MT and Erba HP and Arellano ML and Foster MC and Godwin JE and Ravandi F and Sayre PH et al}},

 doi = {{10.1182/blood-2020-134612}},

 volume = {{136}},

 journal = {{Blood}},

 issue = {{Supplement 1}},

 pages = {{19-21}},

 note = {{Accessed on 2026/02/25}}}